Generate a tailored SOP for Dr. Katie Finegan. Improve your application with a focused, well-structured draft.
Katie Finegan is a Senior Lecturer in Cancer Biology Therapy at the University of Manchester, specializing in cellular signaling with a focus on mitogen-activated protein kinases (MAPKs). With 15 years of experience in translational research, her work primarily investigates the role of the ERK5 protein in cancer and fibrotic diseases. Finegan's research has significantly advanced the understanding of MAPK/ERK5 pathways, leading to the development of ERK5-targeted therapeutic agents. Her highly-cited findings have influenced ongoing research and development in cancer treatment. Current projects include creating novel ERK5 inhibitors for treating Triple Negative Breast Cancer and investigating the role of ERK5 in osteosarcoma metastasis. Finegan's interdisciplinary approach integrates drug discovery with biological studies, aiming to transform basic research into innovative therapies that address unmet medical needs in cancer and fibrotic conditions.
University of Manchester • Manchester, England
Teaching and conducting research in cancer biology, focusing on MAPK pathways and their implications in cancer development.
Includes MSc in Advanced Electrical Power Systems and MSc in Communications and Signal Processing.